Viewing nowAnprolan Sustained-release Tablet 300 mg (Sarpogrelate Hydrochloride)
Sarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

MFDS item code 201500368 · Approved 2015.01.23 · Insurance code 641605940
Improvement of ischemic symptoms (ulcers, pain, etc.) in chronic arterial occlusive disease
This medication is used to improve ischemic symptoms such as ulcers, pain, and coldness caused by chronic arterial occlusive disease. The conditions include Buerger's disease, occlusive arteriosclerosis, and diabetic peripheral vascular disease. These symptoms occur due to impaired blood circulation, and this medication helps alleviate the symptoms by improving blood flow. It is effective in reducing patients' discomfort and enhancing the quality of daily life. Therefore, it is used for various ischemic symptoms related to chronic arterial occlusive disease.
Sarpogrelate Hydrochloride sustained-release tablet 300 mg is administered orally once daily after meals. This medication should not be chewed or crushed but taken whole.
This medication should not be used in patients with bleeding as it may worsen the bleeding. It is not safe for pregnant women or women who may become pregnant to take this medication. Women who are menstruating or patients with a tendency to bleed, as well as those taking anticoagulants or antiplatelet agents, should use this medication with caution. Patients with severely impaired renal function or the elderly need to be careful when taking this medication. This medication can cause various adverse reactions such as urticaria, dyspepsia, diarrhea, headache, and cough; any unusual symptoms should be immediately discussed with healthcare professionals. Serious side effects such as bleeding, blood disorders, and liver dysfunction may occur, thus regular blood tests are recommended. Caution is necessary when taken together with anticoagulants or antiplatelet agents as the risk of bleeding increases. It is preferable for pregnant or breastfeeding women not to take this medication; if unavoidable, breastfeeding should be avoided. Safety in children has not been established, so it is advisable not to use this medication. This medication should be kept out of the reach of children, and transferring to another container should be avoided.
Urticaria, hemophilia, capillary fragility syndrome, gastrointestinal ulcers, urinary bleeding, hemoptysis, spontaneous bleeding, severe allergic reactions, high fever, severe rash, blistering, skin peeling, pain in mucous membranes of the mouth/eyes, severe skin adverse reactions, difficulty breathing or shortness of breath, asthma attack, respiratory problems with cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden and severe headache,
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering and should be kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will maintain the effectiveness of the medication and prevent deterioration.
White rectangular film-coated tablet
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Yuhan Corporation

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
(Co., Ltd.) Pharmgen Science

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Haewon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.